{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:16:03Z","timestamp":1786979763154,"version":"build-2736575974"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Self Funding By corresponding author"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00210-023-02629-9","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T06:01:51Z","timestamp":1690264911000},"page":"599-616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The ameliorative effects of topical gemifloxacin alone or in combination with clobetasol propionate on imiquimod-induced model of psoriasis in mice"],"prefix":"10.1007","volume":"397","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1594-4883","authenticated-orcid":false,"given":"Hayder Ridha","family":"Salman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeeb Ahmed","family":"Al-Zubaidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Hamza","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1425-3450","authenticated-orcid":false,"given":"Qassim A.","family":"Zigam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"2629_CR1","first-page":"362","volume":"42","author":"A Abbas","year":"2023","unstructured":"Abbas A, Abd A, Salman H, Abbas Z (2023) The attenuated effects of cimifugin on imiquimod-induced model of psoriasis in mice. Lat Am J Pharm 42:362\u2013369","journal-title":"Lat Am J Pharm"},{"key":"2629_CR2","doi-asserted-by":"publisher","first-page":"3821279","DOI":"10.1155\/2020\/3821279","volume":"2020","author":"I Adwent","year":"2020","unstructured":"Adwent I, Grabarek BO, Kojs-Mro\u017ckiewicz M, Brus R, Staszkiewicz R, Plewka A, Stasiowski M, Lyssek-Boro\u0144 A (2020) The influence of adalimumab and cyclosporine a on the expression profile of the genes related to TGF<i>\u03b2<\/i> signaling pathways in keratinocyte cells treated with lipopolysaccharide A. Mediators Inflamm 2020:3821279. https:\/\/doi.org\/10.1155\/2020\/3821279","journal-title":"Mediators Inflamm"},{"key":"2629_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.25258\/ijddt.11.2.51","volume":"2","author":"NH Ahmed","year":"2021","unstructured":"Ahmed NH, Al-Zubaidy AAK, Qasim BJ (2021) Effect of topical dipyridamole gel in comparison with clobetasol on induced psoriasis in mice. Int J Drug Deliv Technol 2:524\u2013529. https:\/\/doi.org\/10.25258\/ijddt.11.2.51","journal-title":"Int J Drug Deliv Technol"},{"key":"2629_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.37506\/ijfmt.v15i3.15529","volume":"16","author":"NH Ahmed","year":"2022","unstructured":"Ahmed NH, Al-Zubaidy AAK, Qasim BJ (2022) Effect of tadalafil in comparison with clobetasol ointment in induced psoriasis in mice male. Tikrit J Pharm Sci 16:9\u201318. https:\/\/doi.org\/10.37506\/ijfmt.v15i3.15529","journal-title":"Tikrit J Pharm Sci"},{"key":"2629_CR5","doi-asserted-by":"publisher","unstructured":"Al-Hadiya BMH, Mahmoud AMM (2011) Chapter 4 - gemifloxacin. In: Brittain HG (Ed) Profiles of drug substances, excipients and related methodology. Academic Press, 151\u2013168. https:\/\/doi.org\/10.1016\/B978-0-12-387667-6.00004-X","DOI":"10.1016\/B978-0-12-387667-6.00004-X"},{"key":"2629_CR6","doi-asserted-by":"publisher","first-page":"173088","DOI":"10.1016\/j.ejphar.2020.173088","volume":"877","author":"NO Al-Harbi","year":"2020","unstructured":"Al-Harbi NO, Nadeem A, Ahmad SF, Bakheet SA, El-Sherbeeny AM, Ibrahim KE, Alzahrani KS, Al-Harbi MM, Mahmood HM, Alqahtani F, Attia SM, Alotaibi MR (2020) Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells. Eur J Pharmacol 877:173088. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173088","journal-title":"Eur J Pharmacol"},{"key":"2629_CR7","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.jsps.2020.11.011","volume":"28","author":"B Ali Khan","year":"2020","unstructured":"Ali Khan B, Ullah S, Khan MK, Alshahrani SM, Braga VA (2020) Formulation and evaluation of Ocimum basilicum-based emulgel for wound healing using animal model. Saudi Pharm J 28:1842\u20131850. https:\/\/doi.org\/10.1016\/j.jsps.2020.11.011","journal-title":"Saudi Pharm J"},{"key":"2629_CR8","first-page":"3","volume":"32","author":"AMR Al-juhaishi","year":"2021","unstructured":"Al-juhaishi AMR, Al-Zubaidy AAK (2021) Effects of estradiol on imiquimod-induced model of psoriasis in mice. Turk J Physiother Rehabil 32:3","journal-title":"Turk J Physiother Rehabil"},{"key":"2629_CR9","unstructured":"Al-juhaishi AMR, Al-Zubaidy AAK, Al-Mousawy JMM (2021) Effects of Montelukast on imiquimod-induced model of psoriasis in mice. NVEO- Natural Volatiles and Essential Oils Journal 8(6):3160\u20133171"},{"key":"2629_CR10","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ddr.21640","volume":"81","author":"M AlKhalil","year":"2020","unstructured":"AlKhalil M, Al-Hiari Y, Kasabri V, Arabiyat S, Al-Zweiri M, Mamdooh N, Telfah A (2020) Selected pharmacotherapy agents as antiproliferative and anti-inflammatory compounds. Drug Dev Res 81:470\u2013490. https:\/\/doi.org\/10.1002\/ddr.21640","journal-title":"Drug Dev Res"},{"key":"2629_CR11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.31557\/APJCP.2021.22.4.1075","volume":"22","author":"A Al-Nuaimi","year":"2021","unstructured":"Al-Nuaimi A, Al-Hiari Y, Kasabri V, Haddadin R, Mamdooh N, Alalawi S, Khaleel S (2021) A novel class of functionalized synthetic fluoroquinolones with dual antiproliferative - antimicrobial capacities. Asian Pac J Cancer Prev: APJCP 22:1075\u20131086. https:\/\/doi.org\/10.31557\/APJCP.2021.22.4.1075","journal-title":"Asian Pac J Cancer Prev: APJCP"},{"key":"2629_CR12","doi-asserted-by":"publisher","DOI":"10.26452\/IJRPS.V10I2.255","author":"HF Alsaedi","year":"2019","unstructured":"Alsaedi HF, Al-Saedi HFS, Al-zubaidy AA, Ramadhan MAK, Mohammad HA (2019) Effect of metformin gel against imiquimod\u2013induced psoriasis in mice. Int J Res Pharm Sci. https:\/\/doi.org\/10.26452\/IJRPS.V10I2.255","journal-title":"Int J Res Pharm Sci"},{"key":"2629_CR13","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.3390\/app12104849","volume":"12","author":"BA Alyami","year":"2022","unstructured":"Alyami BA, Alqarni AO, Alqahtani YS, Mahnashi MH, Javed Q, Hassan M, Tahir T, Ali A, Kotwica-Mojzych K, Mojzych M (2022) Fluoroquinolones as tyrosinase inhibitors; enzyme kinetics and molecular docking studies to explore their mechanism of action. Appl Sci 12:4849. https:\/\/doi.org\/10.3390\/app12104849","journal-title":"Appl Sci"},{"key":"2629_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.biopha.2018.12.060","volume":"111","author":"KS Alzahrani","year":"2019","unstructured":"Alzahrani KS, Nadeem A, Ahmad SF, Al-Harbi NO, Ibrahim KE, El-Sherbeeny AM, Alhoshani AR, Alshammari MA, Alotaibi MR, Al-Harbi MM (2019) Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis. Biomed Pharmacother 111:347\u2013358. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.060","journal-title":"Biomed Pharmacother"},{"key":"2629_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2147\/ccid.S352654","volume":"15","author":"F Alzeer","year":"2022","unstructured":"Alzeer F, AlOtair H, Aleisa A (2022) Epidemiology and cutaneous manifestations of psoriasis in saudi arabia: a narrative review. Clin Cosmet Investig Dermatol 15:347\u2013355. https:\/\/doi.org\/10.2147\/ccid.S352654","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2629_CR16","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.31557\/apjcp.2019.20.8.2503","volume":"20","author":"S Arabiyat","year":"2019","unstructured":"Arabiyat S, Kasabri V, Al-Hiari Y, Al-Masri I, Alalawi S, Bustanji Y (2019) Dual glycation-inflammation modulation, DPP-IV and pancreatic lipase inhibitory potentials and antiproliferative activity of novel fluoroquinolones. Asian Pac J Cancer Prev 20:2503\u20132514. https:\/\/doi.org\/10.31557\/apjcp.2019.20.8.2503","journal-title":"Asian Pac J Cancer Prev"},{"key":"2629_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1198-743X.2004.00824.x","volume":"10","author":"F Araujo","year":"2004","unstructured":"Araujo F, Slifer T, Li S, Kuver A, Fong L, Remington J (2004) Gemifloxacin inhibits cytokine secretion by lipopolysaccharide stimulated human monocytes at the post-transcriptional level. Clin Microbiol Infect 10:213\u2013219. https:\/\/doi.org\/10.1111\/j.1198-743X.2004.00824.x","journal-title":"Clin Microbiol Infect"},{"key":"2629_CR18","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1080\/08820139.2020.1797778","volume":"50","author":"S Assar","year":"2021","unstructured":"Assar S, Nosratabadi R, Khorramdel Azad H, Masoumi J, Mohamadi M, Hassanshahi G (2021) A review of immunomodulatory effects of fluoroquinolones. Immunol Invest 50:1007\u20131026. https:\/\/doi.org\/10.1080\/08820139.2020.1797778","journal-title":"Immunol Invest"},{"key":"2629_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1465-9921-15-82","volume":"15","author":"C Beisswenger","year":"2014","unstructured":"Beisswenger C, Honecker A, Kamyschnikow A, Bischoff M, Tschernig T, Bals R (2014) Moxifloxacin modulates inflammation during murine pneumonia. Respir Res 15:82. https:\/\/doi.org\/10.1186\/1465-9921-15-82","journal-title":"Respir Res"},{"key":"2629_CR20","doi-asserted-by":"publisher","first-page":"L343","DOI":"10.1152\/ajplung.00030.2006","volume":"292","author":"H Blau","year":"2007","unstructured":"Blau H, Klein K, Shalit I, Halperin D, Fabian I (2007) Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1\/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line. Am J Physiol Lung Cell Mol Physiol 292:L343-352. https:\/\/doi.org\/10.1152\/ajplung.00030.2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2629_CR21","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.3390\/app12147250","volume":"12","author":"E Borsani","year":"2022","unstructured":"Borsani E, Buffoli B, Bonomini F, Rezzani R (2022) The growth factor release from a platelet-rich plasma preparation is influenced by the onset of guttate psoriasis: a case report. Appl Sci 12:7250. https:\/\/doi.org\/10.3390\/app12147250","journal-title":"Appl Sci"},{"key":"2629_CR22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1476-5381.2009.00161.x","volume":"157","author":"LA Bourikas","year":"2009","unstructured":"Bourikas LA, Kolios G, Valatas V, Notas G, Drygiannakis I, Pelagiadis I, Manousou P, Klironomos S, Mouzas IA, Kouroumalis E (2009) Ciprofloxacin decreases survival in HT-29 cells via the induction of TGF-beta1 secretion and enhances the anti-proliferative effect of 5-fluorouracil. Br J Pharmacol 157:362\u2013370. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00161.x","journal-title":"Br J Pharmacol"},{"key":"2629_CR23","doi-asserted-by":"publisher","unstructured":"Brembilla NC, Boehncke W-H (2023) Revisiting the interleukin 17 family of cytokines in psoriasis: pathogenesis and potential targets for innovative therapies. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1186455","DOI":"10.3389\/fimmu.2023.1186455"},{"key":"2629_CR24","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1101\/pdb.prot073411","volume":"2014","author":"RD Cardiff","year":"2014","unstructured":"Cardiff RD, Miller CH, Munn RJ (2014) Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb Protoc 2014:655\u2013658. https:\/\/doi.org\/10.1101\/pdb.prot073411","journal-title":"Cold Spring Harb Protoc"},{"key":"2629_CR25","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1167\/iovs.17-21944","volume":"58","author":"TC Chen","year":"2017","unstructured":"Chen TC, Chang SW (2017) Moxifloxacin modulated TGF-\u03b21-related interleukin-12 secretion in corneal fibroblasts. Invest Ophthalmol vis Sci 58:5692\u20135702. https:\/\/doi.org\/10.1167\/iovs.17-21944","journal-title":"Invest Ophthalmol vis Sci"},{"key":"2629_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00109-013-1083-4","volume":"92","author":"TC Chen","year":"2014","unstructured":"Chen TC, Hsu YL, Tsai YC, Chang YW, Kuo PL, Chen YH (2014) Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells. J Mol Med (berl) 92:53\u201364. https:\/\/doi.org\/10.1007\/s00109-013-1083-4","journal-title":"J Mol Med (berl)"},{"key":"2629_CR27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4103\/ijd.ijd_569_22","volume":"67","author":"S Chhabra","year":"2022","unstructured":"Chhabra S, Dogra S, Sharma K, Raychaudhuri SK, Raychaudhuri SP (2022) Recent update on immunopathogenesis of psoriasis. Indian J Dermatol 67:360\u2013373. https:\/\/doi.org\/10.4103\/ijd.ijd_569_22","journal-title":"Indian J Dermatol"},{"key":"2629_CR28","doi-asserted-by":"publisher","first-page":"628","DOI":"10.4103\/0253-7613.89815","volume":"43","author":"S Choudhury","year":"2011","unstructured":"Choudhury S, Chatterjee S, Sarkar DK, Dutta RN (2011) Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: a randomized controlled trial. Indian J Pharmacol 43:628\u2013631. https:\/\/doi.org\/10.4103\/0253-7613.89815","journal-title":"Indian J Pharmacol"},{"key":"2629_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/17460441.2018.1463214","volume":"13","author":"SY Chuang","year":"2018","unstructured":"Chuang SY, Lin CH, Sung CT, Fang JY (2018) Murine models of psoriasis and their usefulness for drug discovery. Expert Opin Drug Discov 13:551\u2013562. https:\/\/doi.org\/10.1080\/17460441.2018.1463214","journal-title":"Expert Opin Drug Discov"},{"key":"2629_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejps.2018.01.018","volume":"115","author":"RS Darweesh","year":"2018","unstructured":"Darweesh RS, Sakagami M (2018) In vitro lung epithelial cell transport and anti-interleukin-8 releasing activity of liposomal ciprofloxacin. Eur J Pharm Sci 115:68\u201376. https:\/\/doi.org\/10.1016\/j.ejps.2018.01.018","journal-title":"Eur J Pharm Sci"},{"key":"2629_CR31","first-page":"22","volume":"13","author":"JQ Del Rosso","year":"2020","unstructured":"Del Rosso JQ (2020) Topical corticosteroid therapy for psoriasis-a review of clobetasol propionate 0.025% cream and the clinical relevance of penetration modification. J Clin Aesthet Dermatol 13:22\u201329 (32308782)","journal-title":"J Clin Aesthet Dermatol"},{"key":"2629_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.18231\/j.ijfmts.2020.026","volume":"5","author":"V Dhingra","year":"2021","unstructured":"Dhingra V (2021) Forensic detection and identification of gemifloxacin in autopsy tissue. IP Int J Forensic Med Toxicol Sci 5:111\u2013112. https:\/\/doi.org\/10.18231\/j.ijfmts.2020.026","journal-title":"IP Int J Forensic Med Toxicol Sci"},{"key":"2629_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13568-022-01378-x","volume":"12","author":"MH El-Gayar","year":"2022","unstructured":"El-Gayar MH, Ishak RAH, Esmat A, Aboulwafa MM, Aboshanab KM (2022) Evaluation of lyophilized royal jelly and garlic extract emulgels using a murine model infected with methicillin-resistant Staphylococcus aureus. AMB Express 12:37. https:\/\/doi.org\/10.1186\/s13568-022-01378-x","journal-title":"AMB Express"},{"key":"2629_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2147\/ccid.S171403","volume":"11","author":"HH El-Hadidi","year":"2018","unstructured":"El-Hadidi HH, Hassan AS, El-Hanafy G, Amr KS, Abdelmesih SF, Abdelhamid MF (2018) Transforming growth factor-\u03b21 gene polymorphism in psoriasis vulgaris. Clin Cosmet Investig Dermatol 11:415\u2013419. https:\/\/doi.org\/10.2147\/ccid.S171403","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2629_CR35","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1021\/acsomega.8b03428","volume":"4","author":"CA Fief","year":"2019","unstructured":"Fief CA, Hoang KG, Phipps SD, Wallace JL, Deweese JE (2019) Examining the impact of antimicrobial fluoroquinolones on human DNA topoisomerase II\u03b1 and II\u03b2. ACS Omega 4:4049\u20134055. https:\/\/doi.org\/10.1021\/acsomega.8b03428","journal-title":"ACS Omega"},{"key":"2629_CR36","doi-asserted-by":"publisher","first-page":"129248","DOI":"10.1016\/j.molstruc.2020.129248","volume":"1224","author":"FD Firuzabadi","year":"2021","unstructured":"Firuzabadi FD, Asadi Z (2021) Experimental and computational studies of the interaction of gemifloxacin and manganese (II) gemifloxacin complex with DNA. J Mol Struct 1224:129248. https:\/\/doi.org\/10.1016\/j.molstruc.2020.129248","journal-title":"J Mol Struct"},{"key":"2629_CR37","doi-asserted-by":"publisher","unstructured":"Franz T, Negele J, Bruno P, B\u00f6ttcher M, Mitchell-Flack M, Reemts L, Krone A, Mougiakakos D, M\u00fcller AJ, Zautner AE, Kahlfuss S (2022) Pleiotropic effects of antibiotics on T cell metabolism and T cell-mediated immunity. Front Microbiol 13. https:\/\/doi.org\/10.3389\/fmicb.2022.975436","DOI":"10.3389\/fmicb.2022.975436"},{"key":"2629_CR38","doi-asserted-by":"publisher","first-page":"204062231983064","DOI":"10.1177\/2040622319830646","volume":"10","author":"JW Frew","year":"2019","unstructured":"Frew JW, Hawkes JE, Krueger JG (2019) Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms. Ther Adv Chron Dis 10:2040622319830646. https:\/\/doi.org\/10.1177\/2040622319830646","journal-title":"Ther Adv Chron Dis"},{"key":"2629_CR39","doi-asserted-by":"publisher","first-page":"e0281265","DOI":"10.1371\/journal.pone.0281265","volume":"18","author":"SA Gonz\u00e1lez-Ch\u00e1vez","year":"2023","unstructured":"Gonz\u00e1lez-Ch\u00e1vez SA, Salas-Leiva JS, Salas-Leiva DE, L\u00f3pez-Loeza SM, Sausameda-Garc\u00eda J, Orrantia-Borunda E, Burgos-Vargas R, Alvarado-J\u00e1quez MF, Torres-Quintana M, Cuevas-Mart\u00ednez R, Chaparro-Barrera E, Mar\u00edn-Terrazas C, Espino-Sol\u00eds GP, Romero-L\u00f3pez JP, Bernal-Alferes BJ, Pacheco-Tena C (2023) Levofloxacin induces differential effects in the transcriptome between the gut, peripheral and axial joints in the Spondyloarthritis DBA\/1 mice: improvement of intestinal dysbiosis and the overall inflammatory process. PLoS One 18:e0281265. https:\/\/doi.org\/10.1371\/journal.pone.0281265","journal-title":"PLoS One"},{"key":"2629_CR40","doi-asserted-by":"publisher","first-page":"106258","DOI":"10.1016\/j.intimp.2020.106258","volume":"81","author":"Y Hao","year":"2020","unstructured":"Hao Y, Peng B, Che D, Zheng Y, Kong S, Liu R, Shi J, Han H, Wang J, Cao J, Zhang Y, Gao J, He L, Geng S (2020) Imiquimod-related dermatitis is mainly mediated by mast cell degranulation via Mas-related G-protein coupled receptor B2. Int Immunopharmacol 81:106258. https:\/\/doi.org\/10.1016\/j.intimp.2020.106258","journal-title":"Int Immunopharmacol"},{"key":"2629_CR41","doi-asserted-by":"publisher","first-page":"270","DOI":"10.18203\/2319-2003.ijbcp20210556","volume":"10","author":"M Hazra","year":"2021","unstructured":"Hazra M (2021) A multivariate comparative clinical pharmacotherapeutic efficacy and chronopharmacovigilance assessment study of ofloxacin, one of the commonplace, TGF\u03b21 inducing and telomerase impairing fluoroquinolones, in treating acute gastroenteritis, chronic obstructive pulmonary disease, new drug-sensitive tuberculosis, recurrent mixed cutaneous infections, and post-surgical refractory wound infections, among the global patients, with heterogenous pharmacogeographic and pharmacogenomic constitution. Int J Basic Clin Pharmacol 10:270\u2013280. https:\/\/doi.org\/10.18203\/2319-2003.ijbcp20210556","journal-title":"Int J Basic Clin Pharmacol"},{"key":"2629_CR42","first-page":"32","volume":"22","author":"Q-Z He","year":"2016","unstructured":"He Q-Z, Hu Q-S (2016) Influence of levofloxacin on soluble selection, interleukin, adhesion molecule and pulmonary surfactant protein of patients with pulmonary tuberculosis. J Hainan Med Univ 22:32\u201334","journal-title":"J Hainan Med Univ"},{"key":"2629_CR43","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1080\/09546634.2020.1724250","volume":"32","author":"T Hoegsberg","year":"2021","unstructured":"Hoegsberg T, Iversen L, Lange MM, Bissonette R, Carvalho AVE, van de Kerkhof PC, Kirby B, Kleyn CE, van der Walt JM, Wu JJ, Lynde CW (2021) Topical treatment of psoriasis: questionnaire results on topical therapy as long-term continuous treatment and use on specific body sites. J Dermatol Treat 32:916\u2013921. https:\/\/doi.org\/10.1080\/09546634.2020.1724250","journal-title":"J Dermatol Treat"},{"key":"2629_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-818731-9.00144-0","author":"T Hori","year":"2021","unstructured":"Hori T, Owusu YB, Sun D (2021) US FDA-approved antibiotics during the 21st century. Ref Module Biomed Sci. https:\/\/doi.org\/10.1016\/B978-0-12-818731-9.00144-0","journal-title":"Ref Module Biomed Sci"},{"key":"2629_CR45","doi-asserted-by":"publisher","first-page":"e13339","DOI":"10.1111\/srt.13339","volume":"29","author":"X Hua","year":"2023","unstructured":"Hua X, Li J, Shang M, He W, Gao P, Min L, Peng X (2023) Pathogenesis of psoriasis via miR-149\u20135p\/AKT1axis by long noncoding RNA BLACAT1. Skin Res Technol 29:e13339. https:\/\/doi.org\/10.1111\/srt.13339","journal-title":"Skin Res Technol"},{"key":"2629_CR46","doi-asserted-by":"publisher","unstructured":"Huang CY, Yang JL, Chen JJ, Tai SB, Yeh YH, Liu PF, Lin MW, Chung CL, Chen CL (2021) Fluoroquinolones suppress TGF-\u03b2 and PMA-induced MMP-9 production in cancer cells: implications in repurposing quinolone antibiotics for cancer treatment. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms222111602","DOI":"10.3390\/ijms222111602"},{"key":"2629_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/antibiotics6040026","volume":"6","author":"T Idowu","year":"2017","unstructured":"Idowu T, Schweizer F (2017) Ubiquitous nature of fluoroquinolones: the oscillation between antibacterial and anticancer activities. Antibiotics (basel, Switzerland) 6:26. https:\/\/doi.org\/10.3390\/antibiotics6040026","journal-title":"Antibiotics (basel, Switzerland)"},{"key":"2629_CR48","doi-asserted-by":"publisher","unstructured":"Indrayan A, Malhotra RK (2017) Medical Biostatistics, 4th edn. Chapman & Hall\/CRC, New York, p 1032. https:\/\/doi.org\/10.4324\/9781315100265","DOI":"10.4324\/9781315100265"},{"key":"2629_CR49","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/pharmaceutics12090789","volume":"12","author":"M Jabeen","year":"2020","unstructured":"Jabeen M, Boisgard A-S, Danoy A, El Kholti N, Salvi J-P, Boulieu R, Fromy B, Verrier B, Lamrayah M (2020) Advanced characterization of imiquimod-induced psoriasis-like mouse model. Pharmaceutics 12:789. https:\/\/doi.org\/10.3390\/pharmaceutics12090789","journal-title":"Pharmaceutics"},{"key":"2629_CR50","doi-asserted-by":"publisher","first-page":"229","DOI":"10.15171\/apb.2017.028","volume":"7","author":"S Jagdale","year":"2017","unstructured":"Jagdale S, Pawar S (2017) Gellified emulsion of ofloxacin for transdermal drug delivery system. Adv Pharm Bull 7:229\u2013239. https:\/\/doi.org\/10.15171\/apb.2017.028","journal-title":"Adv Pharm Bull"},{"key":"2629_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.22127\/rjp.2019.93491","volume":"6","author":"M Jahandideh","year":"2019","unstructured":"Jahandideh M, Kharazi P, Jafariazar Z, Fahimi S (2019) Preparation of a topical product from Allium sativum retrieved from Iranian Traditional Medicine. Res J Pharmacogn 6:3\u20136. https:\/\/doi.org\/10.22127\/rjp.2019.93491","journal-title":"Res J Pharmacogn"},{"key":"2629_CR52","doi-asserted-by":"publisher","first-page":"14244","DOI":"10.1038\/s41598-022-18671-1","volume":"12","author":"H Jamshaid","year":"2022","unstructured":"Jamshaid H, Din Fu, Malik M, Mukhtiar M, Choi HG, Ur-Rehman T, Khan GM (2022) A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB\/c mice. Sci Rep 12:14244. https:\/\/doi.org\/10.1038\/s41598-022-18671-1","journal-title":"Sci Rep"},{"key":"2629_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40259-022-00569-z","volume":"37","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Chen Y, Yu Q, Shi Y (2023) Biologic and small-molecule therapies for moderate-to-severe psoriasis: focus on psoriasis comorbidities. BioDrugs 37:35\u201355. https:\/\/doi.org\/10.1007\/s40259-022-00569-z","journal-title":"BioDrugs"},{"key":"2629_CR54","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.4049\/jimmunol.0901662","volume":"184","author":"MM Kaminski","year":"2010","unstructured":"Kaminski MM, Sauer SW, Klemke CD, S\u00fcss D, Okun JG, Krammer PH, G\u00fclow K (2010) Mitochondrial reactive oxygen species control T cell activation by regulating IL-2 and IL-4 expression: mechanism of ciprofloxacin-mediated immunosuppression. J Immunol 184:4827\u20134841. https:\/\/doi.org\/10.4049\/jimmunol.0901662","journal-title":"J Immunol"},{"key":"2629_CR55","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.3390\/ijms20184347","volume":"20","author":"K Kamiya","year":"2019","unstructured":"Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M (2019) Risk factors for the development of psoriasis. Int J Mol Sci 20:4347. https:\/\/doi.org\/10.3390\/ijms20184347","journal-title":"Int J Mol Sci"},{"key":"2629_CR56","doi-asserted-by":"publisher","first-page":"159786","DOI":"10.1155\/2013\/159786","volume":"2013","author":"JY Kan","year":"2013","unstructured":"Kan JY, Hsu YL, Chen YH, Chen TC, Wang JY, Kuo PL (2013) Gemifloxacin, a fluoroquinolone antimicrobial drug, inhibits migration and invasion of human colon cancer cells. Biomed Res Int 2013:159786. https:\/\/doi.org\/10.1155\/2013\/159786","journal-title":"Biomed Res Int"},{"key":"2629_CR57","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1139\/cjc-2020-0162","volume":"98","author":"V Kasabri","year":"2020","unstructured":"Kasabri V, Arabiyat S, Al-Hiari Y, Zalloum H, Almaliti J, Telfah A, Bustanji YK, Alalawi S (2020) Fluoroquinolones as a potentially novel class of antidiabesity and antiproliferative compounds: synthesis and docking studies. Can J Chem 98:635\u2013645. https:\/\/doi.org\/10.1139\/cjc-2020-0162","journal-title":"Can J Chem"},{"key":"2629_CR58","doi-asserted-by":"publisher","unstructured":"Khan R, Mirza MA, Aqil M, Alex TS, Raj N, Manzoor N, Naseef PP, Saheer Kuruniyan M, Iqbal Z (2023) In vitro and in vivo investigation of a dual-targeted nanoemulsion gel for the amelioration of psoriasis. Gels 9.https:\/\/doi.org\/10.3390\/gels9020112","DOI":"10.3390\/gels9020112"},{"key":"2629_CR59","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s40262-014-0152-3","volume":"53","author":"TK Kiang","year":"2014","unstructured":"Kiang TK, H\u00e4feli UO, Ensom MH (2014) A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring. Clin Pharmacokinet 53:695\u2013730. https:\/\/doi.org\/10.1007\/s40262-014-0152-3","journal-title":"Clin Pharmacokinet"},{"key":"2629_CR60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s40261-013-0164-z","volume":"34","author":"MJ Kim","year":"2014","unstructured":"Kim MJ, Lim HS, Cho SH, Bae KS (2014) Comparative pharmacokinetics and bioavailability of gemifloxacin administered as an intravenous 200 mg formulation or an oral 320 mg tablet. Clin Drug Investig 34:195\u2013201. https:\/\/doi.org\/10.1007\/s40261-013-0164-z","journal-title":"Clin Drug Investig"},{"key":"2629_CR61","doi-asserted-by":"publisher","first-page":"7052560","DOI":"10.1155\/2017\/7052560","volume":"2017","author":"SJ Kim","year":"2017","unstructured":"Kim SJ, Jang YW, Hyung KE, Lee DK, Hyun KH, Park SY, Park ES, Hwang KW (2017) Therapeutic effects of methanol extract from Euphorbia kansui Radix on imiquimod-induced psoriasis. J Immunol Res 2017:7052560. https:\/\/doi.org\/10.1155\/2017\/7052560","journal-title":"J Immunol Res"},{"key":"2629_CR62","doi-asserted-by":"publisher","unstructured":"Kloskowski T, Fr\u0105ckowiak S, Adamowicz J, Szeliski K, Rasmus M, Drewa T, Pokrywczy\u0144ska M (2022) Quinolones as a potential drug in genitourinary cancer treatment\u2014a literature review. Front Oncol 12. https:\/\/doi.org\/10.3389\/fonc.2022.890337","DOI":"10.3389\/fonc.2022.890337"},{"key":"2629_CR63","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jaad.2021.06.869","volume":"86","author":"JG Krueger","year":"2022","unstructured":"Krueger JG, McInnes IB, Blauvelt A (2022) Tyrosine kinase 2 and Janus kinase-signal transducer and activator of transcription signaling and inhibition in plaque psoriasis. J Am Acad Dermatol 86:148\u2013157. https:\/\/doi.org\/10.1016\/j.jaad.2021.06.869","journal-title":"J Am Acad Dermatol"},{"key":"2629_CR64","doi-asserted-by":"publisher","first-page":"2193661","DOI":"10.1080\/09546634.2023.2193661","volume":"34","author":"L-L Lee","year":"2023","unstructured":"Lee L-L, Huo A-P, Chen S-L (2023) Experiences and coping behaviors of patients with psoriasis: a qualitative study. J Dermatol Treat 34:2193661. https:\/\/doi.org\/10.1080\/09546634.2023.2193661","journal-title":"J Dermatol Treat"},{"key":"2629_CR65","doi-asserted-by":"publisher","first-page":"469","DOI":"10.21037\/atm.2019.08.43","volume":"7","author":"H-T Li","year":"2019","unstructured":"Li H-T, Ye C, Zhou M, Yang Y, Jin Q, Pan C-F (2019) Moxifloxacin suppresses airway inflammation and modulates expression of caveolin-1 and flotillin-1 in airway smooth muscle cells of asthmatic rats. Ann Trans Med 7:469. https:\/\/doi.org\/10.21037\/atm.2019.08.43","journal-title":"Ann Trans Med"},{"key":"2629_CR66","doi-asserted-by":"publisher","unstructured":"Lin ZC, Hsieh PW, Hwang TL, Chen CY, Sung CT, Fang JY (2018) Topical application of anthranilate derivatives ameliorates psoriatic inflammation in a mouse model by inhibiting keratinocyte-derived chemokine expression and neutrophil infiltration. Faseb J: fj201800354. https:\/\/doi.org\/10.1096\/fj.201800354","DOI":"10.1096\/fj.201800354"},{"key":"2629_CR67","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/10717544.2019.1609623","volume":"26","author":"D Liu","year":"2019","unstructured":"Liu D, Wu Q, Zhu Y, Liu Y, Xie X, Li S, Lin H, Chen W, Zhu F (2019) Co-delivery of metformin and levofloxacin hydrochloride using biodegradable thermosensitive hydrogel for the treatment of corneal neovascularization. Drug Deliv 26:522\u2013531. https:\/\/doi.org\/10.1080\/10717544.2019.1609623","journal-title":"Drug Deliv"},{"key":"2629_CR68","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3390\/ph15081010","volume":"15","author":"A-M Maciuca","year":"2022","unstructured":"Maciuca A-M, Munteanu A-C, Mihaila M, Badea M, Olar R, Nitulescu GM, Munteanu CVA, Uivarosi V (2022) A study on repositioning nalidixic acid via lanthanide complexation: synthesis, characterization, cytotoxicity and DNA\/protein binding studies. Pharmaceuticals 15:1010. https:\/\/doi.org\/10.3390\/ph15081010","journal-title":"Pharmaceuticals"},{"key":"2629_CR69","doi-asserted-by":"publisher","unstructured":"Majeed A, Javeed A, Omer MO, Mushtaq MH, Sattar A (2021) Evaluation of immunomodulatory effects of lomefloxacin in mice. Braz J Pharm Sci 56. https:\/\/doi.org\/10.1590\/s2175-97902019000418669","DOI":"10.1590\/s2175-97902019000418669"},{"key":"2629_CR70","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v9i4-a.3451","author":"A Manaswitha","year":"2019","unstructured":"Manaswitha A, Swetha P, Devi N, Babu KN, Shankar K (2019) Oleic acid based emulgel for topical delivery of ofloxacin. J Drug Deliv Ther. https:\/\/doi.org\/10.22270\/jddt.v9i4-a.3451","journal-title":"J Drug Deliv Ther"},{"key":"2629_CR71","doi-asserted-by":"publisher","first-page":"122","DOI":"10.18433\/jpps30335","volume":"22","author":"K Matsui","year":"2019","unstructured":"Matsui K, Kashima A, Motegi A (2019) Norfloxacin, a fluoroquinolone antibiotic, inhibits langerhans cell-mediated Th1 and Th2 cell development. J Pharm Pharm Sci 22:122\u2013130. https:\/\/doi.org\/10.18433\/jpps30335","journal-title":"J Pharm Pharm Sci"},{"key":"2629_CR72","doi-asserted-by":"publisher","first-page":"2249834","DOI":"10.1155\/2022\/2249834","volume":"2022","author":"MV Medovic","year":"2022","unstructured":"Medovic MV, Jakovljevic VL, Zivkovic VI, Jeremic NS, Jeremic JN, Bolevich SB, Ravic Nikolic AB, Milicic VM, Srejovic IM (2022) Psoriasis between autoimmunity and oxidative stress: changes induced by different therapeutic approaches. Oxid Med Cell Longev 2022:2249834. https:\/\/doi.org\/10.1155\/2022\/2249834","journal-title":"Oxid Med Cell Longev"},{"key":"2629_CR73","doi-asserted-by":"publisher","unstructured":"Millanao AR, Mora AY, Villagra NA, Bucarey SA, Hidalgo AA (2021) Biological effects of quinolones: a family of broad-spectrum antimicrobial agents. Molecules 26. https:\/\/doi.org\/10.3390\/molecules26237153","DOI":"10.3390\/molecules26237153"},{"key":"2629_CR74","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.25258\/ijddt.12.3.53","volume":"3","author":"SS Mohammed","year":"2022","unstructured":"Mohammed SS, Kadhim HM, AL-Sudani IM, Musatafa WW (2022) Anti-inflammatory effects of topically applied azilsartan in a mouse model of imiquimod-induced psoriasis. Int J Drug Deliv Technol 3:1249\u20131255. https:\/\/doi.org\/10.25258\/ijddt.12.3.53","journal-title":"Int J Drug Deliv Technol"},{"key":"2629_CR75","doi-asserted-by":"publisher","first-page":"171","DOI":"10.53730\/ijhs.v6nS3.5241","volume":"6","author":"SS Mohammed","year":"2022","unstructured":"Mohammed SS, Kadhim HM, Al-Sudani IM, Musatafa WW (2022b) Study the topical effect of six days use of different lycopene doses on imiquimod-induce psoriasis-like skin inflammation in mice. Int J Health Sci 6:171\u2013185. https:\/\/doi.org\/10.53730\/ijhs.v6nS3.5241","journal-title":"Int J Health Sci"},{"key":"2629_CR76","doi-asserted-by":"publisher","first-page":"252","DOI":"10.32007\/jfacmedbagdad.6441959","volume":"64","author":"S Mustafa Thamer","year":"2023","unstructured":"Mustafa Thamer S, Yahya MQ (2023) The effect of lenalidomide ointment on TNF-\u03b1 tissue levels in mice with imiquimod-induced psoriasis the effect of lenalidomide ointment on TNF-\u03b1 tissue levels in mice with imiquimod-induced psoriasis. J Fac Med Baghdad 64:252\u2013260. https:\/\/doi.org\/10.32007\/jfacmedbagdad.6441959","journal-title":"J Fac Med Baghdad"},{"key":"2629_CR77","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cellsig.2017.02.014","volume":"33","author":"A Nadeem","year":"2017","unstructured":"Nadeem A, Ahmad SF, Al-Harbi NO, El-Sherbeeny AM, Al-Harbi MM, Almukhlafi TS (2017) GPR43 activation enhances psoriasis-like inflammation through epidermal upregulation of IL-6 and dual oxidase 2 signaling in a murine model. Cell Signal 33:59\u201368. https:\/\/doi.org\/10.1016\/j.cellsig.2017.02.014","journal-title":"Cell Signal"},{"key":"2629_CR78","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pnpbp.2017.12.015","volume":"83","author":"A Nadeem","year":"2018","unstructured":"Nadeem A, Ahmad SF, El-Sherbeeny AM, Al-Harbi NO, Bakheet SA, Attia SM (2018) Systemic inflammation in asocial BTBR T(+) tf\/J mice predisposes them to increased psoriatic inflammation. Prog Neuropsychopharmacol Biol Psychiatry 83:8\u201317. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.12.015","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2629_CR79","doi-asserted-by":"publisher","unstructured":"Nair AB, Kumar S, Dalal P, Nagpal C, Dalal S, Rao R, Sreeharsha N, Jacob S (2022) Novel dermal delivery cargos of clobetasol propionate: an update. Pharmaceutics 14. https:\/\/doi.org\/10.3390\/pharmaceutics14020383","DOI":"10.3390\/pharmaceutics14020383"},{"key":"2629_CR80","doi-asserted-by":"publisher","first-page":"137","DOI":"10.25259\/ijdvl_22_2021","volume":"88","author":"S Neema","year":"2022","unstructured":"Neema S, Sandhu S, Gupta A, Jagadeesan S, Vasudevan B (2022) Unconventional treatment options in psoriasis: a review. Indian J Dermatol Venereol Leprol 88:137\u2013143. https:\/\/doi.org\/10.25259\/ijdvl_22_2021","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2629_CR81","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s10156-009-0680-1","volume":"15","author":"H Ogino","year":"2009","unstructured":"Ogino H, Fujii M, Ono M, Maezawa K, Hori S, Kizu J (2009) In vivo and in vitro effects of fluoroquinolones on lipopolysaccharide-induced pro-inflammatory cytokine production. J Infect Chemother 15:168\u2013173. https:\/\/doi.org\/10.1007\/s10156-009-0680-1","journal-title":"J Infect Chemother"},{"key":"2629_CR82","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s13555-021-00518-8","volume":"11","author":"KA Papp","year":"2021","unstructured":"Papp KA, Gniadecki R, Beecker J, Dutz J, Gooderham MJ, Hong C-H, Kirchhof MG, Lynde CW, Maari C, Poulin Y, Vender RB (2021) Psoriasis prevalence and severity by expert elicitation. Dermatol Ther 11:1053\u20131064. https:\/\/doi.org\/10.1007\/s13555-021-00518-8","journal-title":"Dermatol Ther"},{"key":"2629_CR83","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1039\/c9md00120d","volume":"10","author":"TDM Pham","year":"2019","unstructured":"Pham TDM, Ziora ZM, Blaskovich MAT (2019) Quinolone Antibiotics. Medchemcomm 10:1719\u20131739. https:\/\/doi.org\/10.1039\/c9md00120d","journal-title":"Medchemcomm"},{"key":"2629_CR84","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4103\/0019-5154.190105","volume":"61","author":"S Pradhan","year":"2016","unstructured":"Pradhan S, Madke B, Kabra P, Singh AL (2016) Anti-inflammatory and immunomodulatory effects of antibiotics and their use in dermatology. Indian J Dermatol 61:469\u2013481. https:\/\/doi.org\/10.4103\/0019-5154.190105","journal-title":"Indian J Dermatol"},{"key":"2629_CR85","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.actbio.2020.08.020","volume":"115","author":"SS Pukale","year":"2020","unstructured":"Pukale SS, Sharma S, Dalela M, Ak S, Mohanty S, Mittal A, Chitkara D (2020) Multi-component clobetasol-loaded monolithic lipid-polymer hybrid nanoparticles ameliorate imiquimod-induced psoriasis-like skin inflammation in Swiss albino mice. Acta Biomater 115:393\u2013409. https:\/\/doi.org\/10.1016\/j.actbio.2020.08.020","journal-title":"Acta Biomater"},{"key":"2629_CR86","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.31557\/apjcp.2022.23.5.1529","volume":"23","author":"E Qashou","year":"2022","unstructured":"Qashou E, Al-Hiari Y, Kasabri V, AlBashiti R, AlAlawi S, Telfah A, AlHadid A (2022) Antiproliferative activities of lipophililic fluoroquinolones- based scaffold against a panel of solid and liquid cancer cell lines. Asian Pac J Cancer Prev 23:1529\u20131537. https:\/\/doi.org\/10.31557\/apjcp.2022.23.5.1529","journal-title":"Asian Pac J Cancer Prev"},{"key":"2629_CR87","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1567201816666191120120551","volume":"17","author":"AK Ramanunny","year":"2020","unstructured":"Ramanunny AK, Wadhwa S, Singh SK, Sharma DS, Khursheed R, Awasthi A (2020) Treatment strategies against psoriasis: principle, perspectives and practices. Curr Drug Deliv 17:52\u201373. https:\/\/doi.org\/10.2174\/1567201816666191120120551","journal-title":"Curr Drug Deliv"},{"key":"2629_CR88","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/imr.12629","volume":"282","author":"FA Redegeld","year":"2018","unstructured":"Redegeld FA, Yu Y, Kumari S, Charles N, Blank U (2018) Non-IgE mediated mast cell activation. Immunol Rev 282:87\u2013113. https:\/\/doi.org\/10.1111\/imr.12629","journal-title":"Immunol Rev"},{"key":"2629_CR89","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1476-9255-5-11","volume":"5","author":"F Sachse","year":"2008","unstructured":"Sachse F, von Eiff C, Becker K, Rudack C (2008) Anti-inflammatory effects of ciprofloxacin in S. aureus Newman induced nasal inflammation in vitro. J Inflamm 5:11. https:\/\/doi.org\/10.1186\/1476-9255-5-11","journal-title":"J Inflamm"},{"key":"2629_CR90","doi-asserted-by":"publisher","first-page":"25","DOI":"10.30750\/ijpbr.5.1.4","volume":"5","author":"SK Sah","year":"2017","unstructured":"Sah SK, Badola A, Nayak BK (2017) Emulgel: magnifying the application of topical drug delivery. Indian J Pharm Biol Res 5:25\u201333. https:\/\/doi.org\/10.30750\/ijpbr.5.1.4","journal-title":"Indian J Pharm Biol Res"},{"key":"2629_CR91","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jaci.2020.04.034","volume":"147","author":"MP Sch\u00f6n","year":"2021","unstructured":"Sch\u00f6n MP, Manzke V, Erpenbeck L (2021) Animal models of psoriasis\u2014highlights and drawbacks. J Allergy Clin Immunol 147:439\u2013455. https:\/\/doi.org\/10.1016\/j.jaci.2020.04.034","journal-title":"J Allergy Clin Immunol"},{"key":"2629_CR92","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/09546634.2020.1729335","volume":"33","author":"S Segaert","year":"2022","unstructured":"Segaert S, Calzavara-Pinton P, de la Cueva P, Jalili A, Lons Danic D, Pink AE, Tha\u00e7i D, Gooderham M (2022) Long-term topical management of psoriasis: the road ahead. J Dermatol Treat 33:111\u2013120. https:\/\/doi.org\/10.1080\/09546634.2020.1729335","journal-title":"J Dermatol Treat"},{"key":"2629_CR93","doi-asserted-by":"publisher","first-page":"83","DOI":"10.55262\/fabadeczacilik.1078882","volume":"1","author":"S Shafiulla","year":"2022","unstructured":"Shafiulla S, Dhaneshwar S (2022) Recent advancements in antipsoriatic therapy: an update. Fabad J Pharm Sci 1:83\u2013108. https:\/\/doi.org\/10.55262\/fabadeczacilik.1078882","journal-title":"Fabad J Pharm Sci"},{"key":"2629_CR94","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/jac\/dki441","volume":"57","author":"I Shalit","year":"2006","unstructured":"Shalit I, Halperin D, Haite D, Levitov A, Romano J, Osherov N, Fabian I (2006) Anti-inflammatory effects of moxifloxacin on IL-8, IL-1beta and TNF-alpha secretion and NFkappaB and MAP-kinase activation in human monocytes stimulated with Aspergillus fumigatus. J Antimicrob Chemother 57:230\u2013235. https:\/\/doi.org\/10.1093\/jac\/dki441","journal-title":"J Antimicrob Chemother"},{"key":"2629_CR95","doi-asserted-by":"publisher","first-page":"877","DOI":"10.4314\/tjpr.v12i6.3","volume":"12","author":"M Shukr","year":"2013","unstructured":"Shukr M, Metwally GF (2013) Evaluation of topical gel bases formulated with various essential oils for antibacterial activity against methicillin-resistant Staphylococcus aureus. Trop J Pharm Res 12:877\u2013884. https:\/\/doi.org\/10.4314\/tjpr.v12i6.3","journal-title":"Trop J Pharm Res"},{"key":"2629_CR96","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2147\/copd.S55419","volume":"9","author":"R Siva","year":"2014","unstructured":"Siva R, Bafadhel M, Monteiro W, Brightling CE, Pavord ID (2014) Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial. Int J Chron Obstruct Pulmon Dis 9:179\u2013186. https:\/\/doi.org\/10.2147\/copd.S55419","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2629_CR97","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fmicb.2019.00236","volume":"10","author":"Z Stehlikova","year":"2019","unstructured":"Stehlikova Z, Kostovcikova K, Kverka M, Rossmann P, Dvorak J, Novosadova I, Kostovcik M, Coufal S, Srutkova D, Prochazkova P (2019) Crucial role of microbiota in experimental psoriasis revealed by a gnotobiotic mouse model. Front Microbiol 10:236. https:\/\/doi.org\/10.3389\/fmicb.2019.00236","journal-title":"Front Microbiol"},{"key":"2629_CR98","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10787-022-01131-7","volume":"31","author":"S Sulthana","year":"2023","unstructured":"Sulthana S, Chary PS, Bhavana V, Pardhi E, Singh SB, Mehra NK (2023) Development and evaluation emulgel for effective management of the imiquimod-induced psoriasis. Inflammopharmacology 31:301\u2013320. https:\/\/doi.org\/10.1007\/s10787-022-01131-7","journal-title":"Inflammopharmacology"},{"key":"2629_CR99","doi-asserted-by":"publisher","DOI":"10.25258\/ijddt.9.1.11","author":"J Swati","year":"2019","unstructured":"Swati J, Priyanka M (2019) Optimization of sumatriptan succinate transdermal emulgel for treatment of migraine. Int J Drug Deliv Technol. https:\/\/doi.org\/10.25258\/ijddt.9.1.11","journal-title":"Int J Drug Deliv Technol"},{"key":"2629_CR100","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ejp.768","volume":"20","author":"JC Szepietowski","year":"2016","unstructured":"Szepietowski JC, Reich A (2016) Pruritus in psoriasis: an update. Eur J Pain 20:41\u201346. https:\/\/doi.org\/10.1002\/ejp.768","journal-title":"Eur J Pain"},{"key":"2629_CR101","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41429-020-0278-5","volume":"73","author":"K Tabara","year":"2020","unstructured":"Tabara K, Tamura R, Nakamura A, Mori S, Kitano T, Fujikawa K, Fujikawa M, Okamoto K, Kanayama S, Uratsuji H, Ikeda F, Matsumoto T (2020) Anti-inflammatory effects of ozenoxacin, a topical quinolone antimicrobial agent. J Antibiot 73:247\u2013254. https:\/\/doi.org\/10.1038\/s41429-020-0278-5","journal-title":"J Antibiot"},{"key":"2629_CR102","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1080\/03639045.2021.1993889","volume":"47","author":"M Talat","year":"2021","unstructured":"Talat M, Zaman M, Khan R, Jamshaid M, Akhtar M, Mirza AZ (2021) Emulgel: an effective drug delivery system. Drug Dev Ind Pharm 47:1193\u20131199. https:\/\/doi.org\/10.1080\/03639045.2021.1993889","journal-title":"Drug Dev Ind Pharm"},{"key":"2629_CR103","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s40261-021-01072-z","volume":"41","author":"SY Tan","year":"2021","unstructured":"Tan SY, Chandran NS, Choi EC-E (2021) Steroid phobia: is there a basis? A review of topical steroid safety, addiction and withdrawal. Clin Drug Investig 41:835\u2013842. https:\/\/doi.org\/10.1007\/s40261-021-01072-z","journal-title":"Clin Drug Investig"},{"key":"2629_CR104","doi-asserted-by":"publisher","first-page":"e12946","DOI":"10.1111\/sji.12946","volume":"92","author":"LL Ten Bergen","year":"2020","unstructured":"Ten Bergen LL, Petrovic A, Krogh Aarebrot A, Appel S (2020) The TNF\/IL-23\/IL-17 axis-Head-to-head trials comparing different biologics in psoriasis treatment. Scand J Immunol 92:e12946. https:\/\/doi.org\/10.1111\/sji.12946","journal-title":"Scand J Immunol"},{"key":"2629_CR105","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.phrs.2017.08.012","volume":"125","author":"I Todd","year":"2017","unstructured":"Todd I, Negm OH, Reps J, Radford P, Figueredo G, McDermott EM, Drewe E, Powell RJ, Bainbridge S, Hamed M, Crouch S, Garibaldi J, St-Gallay S, Fairclough LC, Tighe PJ (2017) A signalome screening approach in the autoinflammatory disease TNF receptor associated periodic syndrome (TRAPS) highlights the anti-inflammatory properties of drugs for repurposing. Pharmacol Res 125:188\u2013200. https:\/\/doi.org\/10.1016\/j.phrs.2017.08.012","journal-title":"Pharmacol Res"},{"key":"2629_CR106","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1080\/17512433.2019.1665027","volume":"12","author":"YC Tsai","year":"2019","unstructured":"Tsai YC, Tsai TF (2019) A review of antibiotics and psoriasis: induction, exacerbation, and amelioration. Expert Rev Clin Pharmacol 12:981\u2013989. https:\/\/doi.org\/10.1080\/17512433.2019.1665027","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2629_CR107","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1574-695X.2010.00755.x","volume":"61","author":"R Tsivkovskii","year":"2011","unstructured":"Tsivkovskii R, Sabet M, Tarazi Z, Griffith DC, Lomovskaya O, Dudley MN (2011) Levofloxacin reduces inflammatory cytokine levels in human bronchial epithelia cells: implications for aerosol MP-376 (levofloxacin solution for inhalation) treatment of chronic pulmonary infections. FEMS Immunol Med Microbiol 61:141\u2013146. https:\/\/doi.org\/10.1111\/j.1574-695X.2010.00755.x","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2629_CR108","doi-asserted-by":"publisher","unstructured":"Ullah A, Ahmad S, Ali N, Rahman SU, Hussain H, Alghamdi S, Almehmadi M, Dablool AS, Bannunah AM, Bukhari SH, Almarshad F (2022) Insulinotropic potential of moxifloxacin and gemifloxacin: an in vivo rabbits model study followed by randomized phase I clinical trial. Antibiotics (Basel) 11. https:\/\/doi.org\/10.3390\/antibiotics11020148","DOI":"10.3390\/antibiotics11020148"},{"key":"2629_CR109","doi-asserted-by":"publisher","first-page":"985","DOI":"10.22038\/ijbms.2016.7599","volume":"19","author":"M Umair","year":"2016","unstructured":"Umair M, Javeed A, Ghafoor A, Ashraf MA (2016) Immunomodulatory activities of gemifloxacin in mice. Iran J Basic Med Sci 19:985\u2013992. https:\/\/doi.org\/10.22038\/ijbms.2016.7599","journal-title":"Iran J Basic Med Sci"},{"key":"2629_CR110","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ijantimicag.2011.05.011","volume":"38","author":"CM Vallet","year":"2011","unstructured":"Vallet CM, Marquez B, Ngabirano E, Lemaire S, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F (2011) Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic\/pharmacodynamic model of uninfected and infected macrophages. Int J Antimicrob Agents 38:249\u2013256. https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.05.011","journal-title":"Int J Antimicrob Agents"},{"key":"2629_CR111","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L Van Der Fits","year":"2009","unstructured":"Van Der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus A-M, Florencia E, Prens EP (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J Immunol 182:5836\u20135845. https:\/\/doi.org\/10.4049\/jimmunol.0802999","journal-title":"J Immunol"},{"key":"2629_CR112","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4103\/ijd.ijd_79_22","volume":"67","author":"Q Wang","year":"2022","unstructured":"Wang Q, Yan D, Zheng S, Li M, Li J, Fu X, Fu D, Hu H, Song X, Tian Z (2022) Cytokine profiles and the relationship of disease severity in patients with psoriasis. Indian J Dermatol 67:204. https:\/\/doi.org\/10.4103\/ijd.ijd_79_22","journal-title":"Indian J Dermatol"},{"key":"2629_CR113","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1128\/aac.48.6.1974-1982.2004","volume":"48","author":"T Weiss","year":"2004","unstructured":"Weiss T, Shalit I, Blau H, Werber S, Halperin D, Levitov A, Fabian I (2004) Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines. Antimicrob Agents Chemother 48:1974\u20131982. https:\/\/doi.org\/10.1128\/aac.48.6.1974-1982.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2629_CR114","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1177\/1060028018786510","volume":"52","author":"C Wren","year":"2018","unstructured":"Wren C, Bell E, Eiland LS (2018) Ozenoxacin: a novel topical quinolone for impetigo. Ann Pharmacother 52:1233\u20131237. https:\/\/doi.org\/10.1177\/1060028018786510","journal-title":"Ann Pharmacother"},{"key":"2629_CR115","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jdermsci.2016.12.003","volume":"85","author":"C Xiao","year":"2017","unstructured":"Xiao C, Zhu Z, Sun S, Gao J, Fu M, Liu Y, Wang G, Yao X, Li W (2017) Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis. J Dermatol Sci 85:170\u2013177. https:\/\/doi.org\/10.1016\/j.jdermsci.2016.12.003","journal-title":"J Dermatol Sci"},{"key":"2629_CR116","doi-asserted-by":"publisher","first-page":"644952","DOI":"10.3389\/fphar.2021.644952","volume":"12","author":"J Xie","year":"2021","unstructured":"Xie J, Huang S, Huang H, Deng X, Yue P, Lin J, Yang M, Han L, Zhang D-K (2021) Advances in the application of natural products and the novel drug delivery systems for psoriasis. Front Pharmacol 12:644952\u2013644952. https:\/\/doi.org\/10.3389\/fphar.2021.644952","journal-title":"Front Pharmacol"},{"key":"2629_CR117","doi-asserted-by":"publisher","first-page":"105315","DOI":"10.1016\/j.micpath.2021.105315","volume":"162","author":"X Xie","year":"2022","unstructured":"Xie X, Zhang W, Chen X, Wu D, Cao Y (2022) Norfloxacin suppresses Leptospira-induced inflammation through inhibiting p65 and ERK phosphorylation and NLRP3 inflammasome activation. Microb Pathog 162:105315. https:\/\/doi.org\/10.1016\/j.micpath.2021.105315","journal-title":"Microb Pathog"},{"key":"2629_CR118","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12941-021-00444-9","volume":"20","author":"A Yacouba","year":"2021","unstructured":"Yacouba A, Olowo-Okere A, Yunusa I (2021) Repurposing of antibiotics for clinical management of COVID-19: a narrative review. Ann Clin Microbiol Antimicrob 20:37. https:\/\/doi.org\/10.1186\/s12941-021-00444-9","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2629_CR119","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.biopha.2018.12.119","volume":"111","author":"V Yadav","year":"2019","unstructured":"Yadav V, Talwar P (2019) Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: an underestimated truth. Biomed Pharmacother 111:934\u2013946. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.119","journal-title":"Biomed Pharmacother"},{"key":"2629_CR120","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12964-022-00995-0","volume":"20","author":"B-X Yan","year":"2022","unstructured":"Yan B-X, Chen X-Y, Wang Z-Y, Cui Y-Z, Landeck L, Fu N-C, Yang X-Y, Xu F, Zhou Y, Chen J-Q, Man X-Y (2022) Mupirocin blocks imiquimod-induced psoriasis-like skin lesion by inhibiting epidermal isoleucyl-tRNA synthetase. Cell Commun Signal 20:185. https:\/\/doi.org\/10.1186\/s12964-022-00995-0","journal-title":"Cell Commun Signal"},{"key":"2629_CR121","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/jid.2014.98","volume":"134","author":"R Yoshiki","year":"2014","unstructured":"Yoshiki R, Kabashima K, Honda T, Nakamizo S, Sawada Y, Sugita K, Yoshioka H, Ohmori S, Malissen B, Tokura Y (2014) IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing \u03b3\u03b4 T cells. J Investig Dermatol 134:1912\u20131921. https:\/\/doi.org\/10.1038\/jid.2014.98","journal-title":"J Investig Dermatol"},{"key":"2629_CR122","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.molstruc.2016.05.099","volume":"1122","author":"W Zhang","year":"2016","unstructured":"Zhang W, Li J, Huang Z, Wang H, Luo H, Wang X, Zhou N, Wu C, Bao J (2016) Computer-aided identification of potential TYK2 inhibitors from drug database. J Mol Struct 1122:309\u2013317. https:\/\/doi.org\/10.1016\/j.molstruc.2016.05.099","journal-title":"J Mol Struct"},{"key":"2629_CR123","doi-asserted-by":"publisher","first-page":"110696","DOI":"10.1016\/j.biopha.2020.110696","volume":"131","author":"W Zhou","year":"2020","unstructured":"Zhou W, Hu M, Zang X, Liu Q, Du J, Hu J, Zhang L, Du Z, Xiang Z (2020) Luteolin attenuates imiquimod\u2013induced psoriasis-like skin lesions in BALB\/c mice via suppression of inflammation response. Biomed Pharmacother 131:110696. https:\/\/doi.org\/10.1016\/j.biopha.2020.110696","journal-title":"Biomed Pharmacother"},{"key":"2629_CR124","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12974-019-1538-9","volume":"16","author":"M Zusso","year":"2019","unstructured":"Zusso M, Lunardi V, Franceschini D, Pagetta A, Lo R, Stifani S, Frigo AC, Giusti P, Moro S (2019) Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4\/NF-kB pathway. J Neuroinflammation 16:148. https:\/\/doi.org\/10.1186\/s12974-019-1538-9","journal-title":"J Neuroinflammation"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02629-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02629-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02629-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T11:04:22Z","timestamp":1704798262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02629-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":124,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["2629"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02629-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,25]]},"assertion":[{"value":"28 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institution\u2019s reviewing board et al.-Nahrain University\u2019s College of Medicine surveyed the comprehensive research and licensed the latest installment. The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. A local ethical board reviewed the research protocol, topic data, and consent paperwork and gave its stamp of approval on 4\/11\/2021, according to document 1025.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}